Jingfeng Liu
4 Papers
Jingfeng Liu is an academic researcher. The author has contributed to research in topics: Medicine & Cell cycle checkpoint. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis.
TL;DR: Xanthotoxol (Xan) is the major natural component of the medical plant Angelica dahurica with potential anti-cancer activities as mentioned in this paper , and the effect and underlying mechanism of Xan in non-small cell lung cancer (NSCLC) patients.
14
Correction to: Consensus on the secondary prevention of primary liver cancer
N 6-Methyladenosine Modification Confers Thermal Vulnerability to HPV E7 Oncotranscripts via Reverse Regulation of Its Reader Protein IGF2BP1 Upon Heat Stress
Ling-ling Wang,Guankai Zhan,Yasen Maimaitiyiming,Ying-Hao Su,Jiebo Lin,Shizhen Shen,Wentao He,Jingfeng Liu,Fenfen Wang,Yite Xue,Kunhui Su,Xiaojing Chen,Jian Zhang,Qianqian Wang,Kao-Jung Chang,Shih Hwa Chiou,Mikael Björklund,Hua Naranmandura,Xiaodong Cheng,Chih-Hung Hsu +19 more
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions
TL;DR: The recent status and future directions of the potential use of PSC-derived hepatocytes in treating ALF are discussed and opportunities and challenges of how to promote such strategies in the common applications in clinical treatments are discussed.